Zura Bio Company Insiders

ZURA Stock   1.91  0.05  2.55%   
Zura Bio's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Zura Bio Limited suggests that vertually all insiders are panicking. Zura Bio employs about 30 people. The company is managed by 10 executives with a total tenure of roughly 70 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive.

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2024-11-25Parvinder ThiaraDisposed 1001633 @ 2.73View
2024-09-04Someit SidhuDisposed 51728 @ 3.87View
Monitoring Zura Bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Zura Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.314) % which means that it has lost $0.314 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5505) %, meaning that it created substantial loss on money invested by shareholders. Zura Bio's management efficiency ratios could be used to measure how well Zura Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.24. In addition to that, Return On Capital Employed is expected to decline to -0.36. At present, Zura Bio's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.4 M, whereas Total Assets are forecasted to decline to about 117.3 M.
As of July 19, 2025, Common Stock Shares Outstanding is expected to decline to about 39.2 M. In addition to that, Net Loss is expected to decline to about (42.7 M)

Zura Bio Workforce Comparison

Zura Bio Limited is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 26,011. Zura Bio adds roughly 30.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Zura Bio Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zura Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zura Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zura Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Zura Bio Notable Stakeholders

A Zura Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zura Bio often face trade-offs trying to please all of them. Zura Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zura Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert LisickiPresident COOProfile
Kimberly JDCOO OfficerProfile
Someit MDFounder DirectorProfile
Gary WhaleChief OfficerProfile
David BradyHead DevelopmentProfile
Kiran MBBSChief DevelopmentProfile
Kimberly DavisChief SecretaryProfile
Theresa LowryChief OfficerProfile
Verender BadialChief OfficerProfile
Michael HowellChief MedicineProfile

About Zura Bio Management Performance

The success or failure of an entity such as Zura Bio Limited often depends on how effective the management is. Zura Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zura management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zura management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.25)(0.24)
Return On Capital Employed(0.34)(0.36)
Return On Assets(0.25)(0.24)
Return On Equity(0.31)(0.29)
Please note, the presentation of Zura Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zura Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zura Bio's management manipulating its earnings.

Zura Bio Workforce Analysis

Traditionally, organizations such as Zura Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zura Bio within its industry.

Zura Bio Manpower Efficiency

Return on Zura Bio Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.7M
Net Loss Per Executive5.2M
Working Capital Per Employee5.3M
Working Capital Per Executive15.9M

Complementary Tools for Zura Stock analysis

When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios